169 related articles for article (PubMed ID: 27783661)
1. The High Level of Aberrant Splicing of ISCU in Slow-Twitch Muscle May Involve the Splicing Factor SRSF3.
Rawcliffe DF; Österman L; Lindsten H; Holmberg M
PLoS One; 2016; 11(10):e0165453. PubMed ID: 27783661
[TBL] [Abstract][Full Text] [Related]
2. PTBP1 acts as a dominant repressor of the aberrant tissue-specific splicing of ISCU in hereditary myopathy with lactic acidosis.
Rawcliffe DFR; Österman L; Nordin A; Holmberg M
Mol Genet Genomic Med; 2018 Nov; 6(6):887-897. PubMed ID: 30209894
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific splicing of ISCU results in a skeletal muscle phenotype in myopathy with lactic acidosis, while complete loss of ISCU results in early embryonic death in mice.
Nordin A; Larsson E; Thornell LE; Holmberg M
Hum Genet; 2011 Apr; 129(4):371-8. PubMed ID: 21165651
[TBL] [Abstract][Full Text] [Related]
4. Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect.
Olsson A; Lind L; Thornell LE; Holmberg M
Hum Mol Genet; 2008 Jun; 17(11):1666-72. PubMed ID: 18296749
[TBL] [Abstract][Full Text] [Related]
5. Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy.
Sanaker PS; Toompuu M; Hogan VE; He L; Tzoulis C; Chrzanowska-Lightowlers ZM; Taylor RW; Bindoff LA
Biochim Biophys Acta; 2010 Jun; 1802(6):539-44. PubMed ID: 20206689
[TBL] [Abstract][Full Text] [Related]
6. The defective splicing caused by the ISCU intron mutation in patients with myopathy with lactic acidosis is repressed by PTBP1 but can be derepressed by IGF2BP1.
Nordin A; Larsson E; Holmberg M
Hum Mutat; 2012 Mar; 33(3):467-70. PubMed ID: 22125086
[TBL] [Abstract][Full Text] [Related]
7. Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines.
Holmes-Hampton GP; Crooks DR; Haller RG; Guo S; Freier SM; Monia BP; Rouault TA
Hum Mol Genet; 2016 Dec; 25(23):5178-5187. PubMed ID: 28007899
[TBL] [Abstract][Full Text] [Related]
8. Tissue specificity of a human mitochondrial disease: differentiation-enhanced mis-splicing of the Fe-S scaffold gene ISCU renders patient cells more sensitive to oxidative stress in ISCU myopathy.
Crooks DR; Jeong SY; Tong WH; Ghosh MC; Olivierre H; Haller RG; Rouault TA
J Biol Chem; 2012 Nov; 287(48):40119-30. PubMed ID: 23035118
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide corrects splice abnormality in hereditary myopathy with lactic acidosis.
Sanaker PS; Toompuu M; McClorey G; Bindoff LA
Gene; 2012 Feb; 494(2):231-6. PubMed ID: 22155317
[TBL] [Abstract][Full Text] [Related]
10. Elevated FGF21 secretion, PGC-1α and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle.
Crooks DR; Natarajan TG; Jeong SY; Chen C; Park SY; Huang H; Ghosh MC; Tong WH; Haller RG; Wu C; Rouault TA
Hum Mol Genet; 2014 Jan; 23(1):24-39. PubMed ID: 23943793
[TBL] [Abstract][Full Text] [Related]
11. Clinical manifestation and a new ISCU mutation in iron-sulphur cluster deficiency myopathy.
Kollberg G; Tulinius M; Melberg A; Darin N; Andersen O; Holmgren D; Oldfors A; Holme E
Brain; 2009 Aug; 132(Pt 8):2170-9. PubMed ID: 19567699
[TBL] [Abstract][Full Text] [Related]
12. Transient restoration of succinate dehydrogenase activity after rhabdomyolysis in iron-sulphur cluster deficiency myopathy.
Kollberg G; Melberg A; Holme E; Oldfors A
Neuromuscul Disord; 2011 Feb; 21(2):115-20. PubMed ID: 21196119
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotide therapeutics for iron-sulphur cluster deficiency myopathy.
Kollberg G; Holme E
Neuromuscul Disord; 2009 Dec; 19(12):833-6. PubMed ID: 19846308
[TBL] [Abstract][Full Text] [Related]
14. Loss of SRSF3 in Cardiomyocytes Leads to Decapping of Contraction-Related mRNAs and Severe Systolic Dysfunction.
Ortiz-Sánchez P; Villalba-Orero M; López-Olañeta MM; Larrasa-Alonso J; Sánchez-Cabo F; Martí-Gómez C; Camafeita E; Gómez-Salinero JM; Ramos-Hernández L; Nielsen PJ; Vázquez J; Müller-McNicoll M; García-Pavía P; Lara-Pezzi E
Circ Res; 2019 Jul; 125(2):170-183. PubMed ID: 31145021
[TBL] [Abstract][Full Text] [Related]
15. A novel de novo dominant mutation in
Legati A; Reyes A; Ceccatelli Berti C; Stehling O; Marchet S; Lamperti C; Ferrari A; Robinson AJ; Mühlenhoff U; Lill R; Zeviani M; Goffrini P; Ghezzi D
J Med Genet; 2017 Dec; 54(12):815-824. PubMed ID: 29079705
[TBL] [Abstract][Full Text] [Related]
16. RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell.
Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007
[TBL] [Abstract][Full Text] [Related]
17. Adapted Resistance to the Knockdown Effect of shRNA-Derived Srsf3 siRNAs in Mouse Littermates.
Ajiro M; Jia R; Wang RH; Deng CX; Zheng ZM
Int J Biol Sci; 2015; 11(11):1248-56. PubMed ID: 26435690
[TBL] [Abstract][Full Text] [Related]
18. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
Yang S; Jia R; Bian Z
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress-inducible truncated serine/arginine-rich splicing factor 3 regulates interleukin-8 production in human colon cancer cells.
Kano S; Nishida K; Kurebe H; Nishiyama C; Kita K; Akaike Y; Kajita K; Kurokawa K; Masuda K; Kuwano Y; Tanahashi T; Rokutan K
Am J Physiol Cell Physiol; 2014 Feb; 306(3):C250-62. PubMed ID: 24284797
[TBL] [Abstract][Full Text] [Related]
20. The SR protein SC35 is responsible for aberrant splicing of the E1alpha pyruvate dehydrogenase mRNA in a case of mental retardation with lactic acidosis.
Gabut M; Miné M; Marsac C; Brivet M; Tazi J; Soret J
Mol Cell Biol; 2005 Apr; 25(8):3286-94. PubMed ID: 15798212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
